HAOXI HEALTH TECHNOLOGY LTD

HAO is the NYSE Arca-listed ticker for the Invesco China Small Cap ETF, an exchange-traded fund that seeks to track the performance of small-capitalization Chinese companies. Rather than representing a single operating business, HAO holds a basket of equities, giving investors diversified exposure to China's smaller publicly traded firms. The fund is managed by Invesco and trades on U.S. exchanges like a stock, so its price updates throughout the trading day based on the underlying holdings and market demand.

The live price for HAO changes continuously during U.S. market hours, so the most accurate figure is the latest quote shown on this page. That displayed price reflects the most recent trade and may differ from the fund's net asset value because HAO can trade at a slight premium or discount. For real-time context, compare the on-screen price with the day's open, previous close, and any intraday high or low listed alongside it.

Because HAO is an ETF, valuation is best assessed through its portfolio rather than a single P/E ratio. Review the fund's aggregate price-to-earnings and price-to-book ratios, which are typically published by the sponsor, and compare them with broad China or emerging-market benchmarks. Also consider the premium or discount of HAO's market price to its net asset value, since a persistent gap can signal liquidity or demand imbalances. These figures appear on the page's latest data.

HAO trades on NYSE Arca, so it can generally be purchased through a standard brokerage account that offers U.S.-listed ETFs. Place a buy order using the ticker HAO, choosing a market or limit order based on your preference. Fractional shares may be available at some brokers, and commission-free ETF trading is common, though fees vary by platform. Confirm the order type, quantity, and any applicable costs before submitting.

For HAO, performance analysis focuses on the fund rather than a single company's income statement. Review the fund's net asset value history, total return including distributions, and the performance of its underlying small-cap China holdings. The sponsor's fact sheet and annual reports provide sector weightings, top positions, and expense ratio. Comparing HAO's returns with relevant China small-cap indexes helps frame whether its tracking and selection have been effective.

HAO carries concentrated exposure to Chinese small-cap equities, which can be more volatile and less liquid than larger companies. Investors face country and regulatory risk, currency fluctuations between the yuan and dollar, and the possibility of political or policy changes affecting Chinese markets. As an ETF, HAO also has tracking error and premium/discount risk relative to net asset value. These factors can amplify price swings compared with broad U.S. equity funds.